文献速递腹部CT

结直肠癌患者进行性肌少症可预测生存

Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival.
PubMed 文献 · AJR Am J Roentgenol · 2018-01-24

回顾性纳入101例结直肠癌患者,在诊断时及诊断后6-18个月行CT测量L4水平腰大肌、椎旁肌及总肌肉的骨骼肌指数和平均肌肉衰减度,随访至少5年。腰大肌、椎旁肌及总肌肉骨骼肌指数变化与总生存期的风险比分别为2.27、1.68、1.54(均p<0.05),肌肉指数及衰减度变化与无进展生存期也相关。结论认为诊断后进行性肌少症与总生存期及无进展生存期呈显著负相关预后关联。

要点

  • 结直肠癌诊断后6-18个月CT复查时腰大肌SMI下降与总生存期风险比2.27相关(p<0.05)。
  • 椎旁肌和总肌肉SMI变化与总生存期风险比分别为1.68和1.54(均p<0.05)。
  • 肌肉衰减度变化与总生存期及无进展生存期均相关(均p<0.05)。

核心结论

  • 结直肠癌诊断后进行性肌少症与总生存期和无进展生存期呈显著负相关预后关联。

研究设计与样本

  • 回顾性研究,符合HIPAA,纳入101例结直肠癌患者(平均年龄63.7±13.7岁,男68例、女33例),诊断时及诊断后6-18个月行CT,于L4水平测量腰大肌、椎旁肌及总肌肉的骨骼肌指数和平均肌肉衰减度,随访至少5年,采用单因素和多因素Cox比例风险分析及Kaplan-Meier分析。

诊断标准与关键数值

  • 腰大肌、椎旁肌和总肌肉SMI变化预测总生存期的风险比分别为2.27、1.68、1.54(均p<0.05)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to evaluate the relationship between sarcopenia and overall and progression-free survival in patients with colorectal cancer.

MATERIALS AND METHODS: This study was retrospective and complied with HIPAA. Patients with colorectal cancer who underwent CT at the time of and 6-18 months after diagnosis were included. Patients were followed for at least 5 years after diagnosis. Skeletal muscle index (SMI) and mean muscle attenuation of the psoas and paraspinal muscles at the L4 level determined the degree of sarcopenia. Composite measurements combining psoas and paraspinal muscles (total muscle) were also obtained. Univariate and multivariate Cox proportional hazard analysis was performed to evaluate the association between survival and changes in SMI and changes in attenuation. Kaplan-Meier analysis was also performed.

RESULTS: A total of 101 patients were included (mean age ± SD, 63.7 ± 13.7 years; 68 men, 33 women). The hazard ratios for overall survival were 2.27, 1.68, and 1.54 for changes in SMI of the psoas muscle, paraspinal muscle, and total muscle (all p < 0.05). The hazard ratios for overall survival were 1.14, 1.18, and 1.24 for changes in attenuation of the psoas muscle, paraspinal muscle, and total muscle, respectively (all p < 0.05). The hazard ratios for progression-free survival were 1.33, 1.41, and 1.23 for changes in SMI of the psoas muscle, paraspinal muscle, and total muscle (not statistically significant). The hazard ratios for progression-free survival were 1.10, 1.21, and 1.23 for changes in attenuation of the psoas muscle, paraspinal muscle, and total muscle, respectively (p < 0.05). Kaplan-Meier analysis showed significant differences in overall and progression-free survival based on sex-specific quartiles of muscle quantity and quality.

CONCLUSION: Progressive sarcopenia after diagnosis of colorectal cancer has a significant negative prognostic association with overall and progression-free survival.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Deng CY, Lin YC, Wu JS, et al. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival. AJR Am J Roentgenol. 2018. PMID: 29364725. doi:10.2214/AJR.17.18020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。